BRMS1
Basic information
Region (hg38): 11:66337333-66345125
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BRMS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 20 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 6 | |||||
Total | 0 | 0 | 21 | 4 | 2 |
Variants in BRMS1
This is a list of pathogenic ClinVar variants found in the BRMS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-66337677-C-T | Benign (Feb 26, 2018) | |||
11-66337678-G-A | not specified | Likely benign (Feb 28, 2023) | ||
11-66337699-G-A | not specified | Likely benign (Jun 22, 2021) | ||
11-66337705-G-A | not specified | Uncertain significance (Jul 06, 2024) | ||
11-66337732-A-G | not specified | Likely benign (Jan 08, 2024) | ||
11-66337747-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
11-66337760-A-T | not specified | Uncertain significance (Jul 30, 2024) | ||
11-66337771-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
11-66337777-C-G | not specified | Uncertain significance (Oct 29, 2024) | ||
11-66337801-C-T | not specified | Likely benign (Aug 12, 2021) | ||
11-66338250-T-A | not specified | Uncertain significance (Dec 17, 2023) | ||
11-66338266-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
11-66338273-C-T | not specified | Uncertain significance (Sep 11, 2024) | ||
11-66338725-T-C | not specified | Uncertain significance (Jan 18, 2022) | ||
11-66338767-A-G | not specified | Uncertain significance (Jul 13, 2022) | ||
11-66338774-C-T | not specified | Uncertain significance (Sep 03, 2024) | ||
11-66340190-C-T | not specified | Uncertain significance (Dec 20, 2022) | ||
11-66340202-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
11-66340776-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
11-66340784-G-A | Benign (Feb 26, 2018) | |||
11-66340797-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
11-66340837-C-G | not specified | Uncertain significance (Dec 14, 2021) | ||
11-66340851-T-C | not specified | Uncertain significance (Jul 07, 2024) | ||
11-66340980-T-G | not specified | Uncertain significance (Jun 17, 2024) | ||
11-66341032-A-G | not specified | Uncertain significance (May 11, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BRMS1 | protein_coding | protein_coding | ENST00000425825 | 9 | 7793 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.58e-7 | 0.641 | 125714 | 0 | 34 | 125748 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.107 | 166 | 170 | 0.977 | 0.0000101 | 1880 |
Missense in Polyphen | 47 | 51.471 | 0.91314 | 592 | ||
Synonymous | 0.565 | 63 | 69.0 | 0.913 | 0.00000406 | 543 |
Loss of Function | 1.13 | 13 | 18.2 | 0.715 | 9.59e-7 | 196 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000550 | 0.000544 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000792 | 0.0000791 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000261 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor. Down-regulates transcription activation by NF-kappa-B by promoting the deacetylation of RELA at 'Lys-310'. Promotes HDAC1 binding to promoter regions. Down- regulates expression of anti-apoptotic genes that are controlled by NF-kappa-B. Promotes apoptosis in cells that have inadequate adherence to a substrate, a process called anoikis, and may thereby inhibit metastasis. May be a mediator of metastasis suppression in breast carcinoma. {ECO:0000269|PubMed:14581478, ECO:0000269|PubMed:17000776, ECO:0000269|PubMed:20830743}.;
- Pathway
- HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.157
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.57
Haploinsufficiency Scores
- pHI
- 0.143
- hipred
- Y
- hipred_score
- 0.640
- ghis
- 0.541
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.930
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Brms1
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;apoptotic process;histone deacetylation;negative regulation of NF-kappaB transcription factor activity;regulation of apoptotic process;negative regulation of transcription, DNA-templated;positive regulation of protein deacetylation;positive regulation of anoikis
- Cellular component
- nucleus;nucleoplasm;cytoplasm;Sin3-type complex
- Molecular function
- histone deacetylase activity;protein binding;histone deacetylase binding;NF-kappaB binding